Drug news
SOBI will sell Orfadin in US,Canada and Latin America
Swedish Orphan Biovitrum AB (Sobi) announced that the company has decided to take direct responsibility for Orfadin in the US, Canada, and Latin America by terminating the current distributorship agreement with their partner Rare Disease Therapeutics, Inc.,